Article
NTRK and RET fusion–directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake
8 Jul 2021
Abstract excerpt
BACKGROUNDMolecular characterization in pediatric papillary thyroid cancer (PTC), distinct from adult PTC, is important for developing molecularly targeted therapies for progressive radioiodine-refractory (131I-refractory) PTC.METHODSPTC samples from 106 pediatric patients (age range: 4.3-19.8 years; n = 84 girls, n = 22 boys) who were admitted to SNUH (January 1983-March 2020) were available for genomic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
